Association of urinary melatonin levels and aging-related outcomes in older men

Sleep Medicine

Volumn 23, Issue , 2016, Pages 73-80

  Devore, Elizabeth E ^a   Harrison, Stephanie L ^b   Stone, Katie L ^b   Holton, Kathleen F ^c   Barrett Connor, Elizabeth ^d   Ancoli Israel, Sonia ^d,e   Yaffe, Kristine ^f   Ensrud, Kristine ^g,h,i   Cawthon, Peggy M ^b,f   Redline, Susan ^j   Orwoll, Eric ^k   Schernhammer, Eva S ^a,l,m  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c AMERICAN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Minneapolis VA Healthcare System   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^m Medical University of Vienna   (Austria)

more..

Author keywords

Aging; Cognitive function; Melatonin; Mortality; Physical function

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN; 6-SULFATOXYMELATONIN;

AGED; AGING; ARTICLE; COGNITION; COHORT ANALYSIS; FOLLOW UP; FUNCTIONAL STATUS; HORMONE DETERMINATION; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; URINALYSIS; URINE LEVEL; ANALOGS AND DERIVATIVES; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; FITNESS; MULTICENTER STUDY; PHYSIOLOGY; URINE;

AGED; AGING; CARDIOVASCULAR DISEASES; COGNITION; COHORT STUDIES; HUMANS; MALE; MELATONIN; MORTALITY; PHYSICAL FITNESS;

EID: 84983483182     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2016.07.006     Document Type: Article

References (51)

1. [1] Morris, C.J., Yang, J.N., Scheer, F.A., The impact of the circadian timing system on cardiovascular and metabolic function. Prog Brain Res 199 (2012), 337–358.
2. [2] Beccuti, G., Pannain, S., Sleep and obesity. Curr Opin Clin Nutr Metab Care 14 (2011), 402–412.
3. [3] Antunes, L.C., Levandovski, R., Dantas, G., et al. Obesity and shift work: chronobiological aspects. Nutr Res Rev 23 (2010), 155–168.
4. [4] Shan, Z., Ma, H., Xie, M., et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 38 (2015), 529–537.
5. [5] Gan, Y., Yang, C., Tong, X., et al. Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med 72 (2015), 72–78.
6. [6] Yang, X., Chen, H., Li, S., et al. Association of sleep duration with the morbidity and mortality of coronary artery disease: a meta-analysis of prospective studies. Heart Lung Circ 24:12 (2015), 1180–1190.
7. [7] Vyas, M.V., Garg, A.X., Iansavichus, A.V., et al. Shift work and vascular events: systematic review and meta-analysis. BMJ, 345, 2012, e4800.
8. [8] Paudel, M.L., Taylor, B.C., Ancoli-Israel, S., et al. Rest/activity rhythms and cardiovascular disease in older men. Chronobiol Int 28 (2011), 258–266.
9. [9] Tranah, G.J., Blackwell, T., Stone, K.L., et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 70 (2011), 722–732.
10. [10] Cappuccio, F.P., D'Elia, L., Strazzullo, P., et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33 (2010), 585–592.
11. [11] Paudel, M.L., Taylor, B.C., Ancoli-Israel, S., et al. Rest/activity rhythms and mortality rates in older men: MrOS Sleep Study. Chronobiol Int 27 (2010), 363–377.
12. [12] Tranah, G.J., Blackwell, T., Ancoli-Israel, S., et al. Circadian activity rhythms and mortality: the study of osteoporotic fractures. J Am Geriatr Soc 58 (2010), 282–291.
13. [13] Zuurbier, L.A., Luik, A.I., Hofman, A., et al. Fragmentation and stability of circadian activity rhythms predict mortality: the Rotterdam study. Am J Epidemiol 181 (2015), 54–63.
14. [14] Kondratov, R.V., A role of the circadian system and circadian proteins in aging. Ageing Res Rev 6 (2007), 12–27.
15. [15] Kondratova, A.A., Kondratov, R.V., The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 13 (2012), 325–335.
16. [16] Harfmann, B.D., Schroder, E.A., Esser, K.A., Circadian rhythms, the molecular clock, and skeletal muscle. J Biol Rhythms 30 (2015), 84–94.
17. [17] Hardeland, R., Cardinali, D.P., Srinivasan, V., et al. Melatonin – a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 93 (2011), 350–384.
18. [18] Poeggeler, B., Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 27 (2005), 201–212.
19. [19] Asayama, K., Yamadera, H., Ito, T., et al. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 70 (2003), 334–341.
20. [20] Furio, A.M., Brusco, L.I., Cardinali, D.P., Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study. J Pineal Res 43 (2007), 404–409.
21. [21] Jean-Louis, G., von Gizycki, H., Zizi, F., Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 25 (1998), 177–183.
22. [22] Riemersma-van der Lek, R.F., Swaab, D.F., Twisk, J., et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 299 (2008), 2642–2655.
23. [23] Burns, A., Allen, H., Tomenson, B., et al. Bright light therapy for agitation in dementia: a randomized controlled trial. Int Psychogeriatr 21 (2009), 711–721.
24. [24] Fontana Gasio, P., Krauchi, K., Cajochen, C., et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol 38 (2003), 207–216.
25. [25] Graf, A., Wallner, C., Schubert, V., et al. The effects of light therapy on mini-mental state examination scores in demented patients. Biol Psychiatry 50 (2001), 725–727.
26. [26] Yamadera, H., Ito, T., Suzuki, H., et al. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci 54 (2000), 352–353.
27. [27] Wade, A.G., Farmer, M., Harari, G., et al. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clin Interv Aging 9 (2014), 947–961.
28. [28] Obayashi, K., Saeki, K., Iwamoto, J., et al. Physiological levels of melatonin relate to cognitive function and depressive symptoms: the HEIJO-KYO cohort. J Clin Endocrinol Metab 100 (2015), 3090–3096.
29. [29] Obayashi, K., Saeki, K., Maegawa, T., et al. Melatonin secretion and muscle strength in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. J Gerontol A Biol Sci Med Sci 71:9 (2016), 1235–1240.
30. [30] Blank, J.B., Cawthon, P.M., Carrion-Petersen, M.L., et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 26 (2005), 557–568.
31. [31] Orwoll, E., Blank, J.B., Barrett-Connor, E., et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study – a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26 (2005), 569–585.
32. [32] Schernhammer, E.S., Rosner, B., Willett, W.C., et al. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 13 (2004), 936–943.
33. [33] Lushington, K., Dawson, D., Encel, N., et al. Urinary 6-sulfatoxymelatonin cycle-to-cycle variability. Chronobiol Int 13 (1996), 411–421.
34. [34] Teng, E.L., Chui, H.C., The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987), 314–318.
35. [35] Reitan, R., Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8 (1958), 271–276.
36. [36] Reitan, R.M., The relation of the trail making test to organic brain damage. J Consult Psychol 19 (1955), 393–394.
37. [37] Lewis, R.F., Rennick, P.M., Manual for the repeatable cognitive-perceptual-motor battery. 1979, Axon Publishing, Grosse Point Park, MI.
38. [38] Washburn, R.A., Smith, K.W., Jette, A.M., et al. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46 (1993), 153–162.
39. [39] Sheikh, J., Yesavage, J., Geriatric Depresion Scale: recent evidence and development of a shorter version. Clinical Gerontology: A Guide to Assessment and Intervention. 1986, The Haworth Press, New York, 165–173.
40. [40] Ware, J.E., Kosinski, M., Keller, S.D., SF-12: How to score the SF-12 physical and mental health summary scores. 3rd ed, 1998, QualityMetric, Inc., Lincoln, RI.
41. [41] Pahor, M., Chrischilles, E.A., Guralnik, J.M., et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10 (1994), 405–411.
42. [42] Fares, A., Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients. J Cardiovasc Dis Res 2 (2011), 153–155.
43. [43] Jansen, S.L., Forbes, D.A., Duncan, V., et al. Melatonin for cognitive impairment. Cochrane Database Syst Rev(1), 2006 CD003802.
44. [44] Xu, J., Wang, L.L., Dammer, E.B., et al. Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials. Am J Alzheimers Dis Other Demen 30:5 (2015), 439–447.
45. [45] Walsh, C.M., Blackwell, T., Tranah, G.J., et al. Weaker circadian activity rhythms are associated with poorer executive function in older women. Sleep 37 (2014), 2009–2016.
46. [46] Baskett, J.J., Cockrem, J.F., Antunovich, T.A., Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res 24 (1998), 58–61.
47. [47] Graham, C., Cook, M.R., Kavet, R., et al. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 24 (1998), 230–238.
48. [48] Mirick, D.K., Bhatti, P., Chen, C., et al. Night shift work and levels of 6-sulfatoxymelatonin and cortisol in men. Cancer Epidemiol Biomarkers Prev 22 (2013), 1079–1087.
49. [49] Arendt, J., Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 3 (1998), 13–22.
50. [50] Blackwell, T., Yaffe, K., Ancoli-Israel, S., et al. Associations between sleep architecture and sleep-disordered breathing and cognition in older community-dwelling men: the Osteoporotic Fractures in Men Sleep Study. J Am Geriatr Soc 59 (2011), 2217–2225.
51. [51] Blackwell, T., Yaffe, K., Laffan, A., et al. Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study. Sleep 37 (2014), 655–663.